The global aerosol delivery devices market size reached US$ 44.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 63.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028. More Info:- https://www.imarcgroup.com/aerosol-delivery-devices-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Aerosol Delivery Devices
Market Research and Forecast
Report 2023-2028
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Aerosol Delivery Devices Market Research Report 2023-2028:
According to the latest report by IMARC Group, titled "Aerosol Delivery Devices Market: Global
Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global aerosol
delivery devices market size reached US$ 44.4 Billion in 2022.
Aerosol delivery devices refer to an advanced method of drug administration wherein a drug is
directly delivered to the lungs for a systemic effect. Some commonly used aerosol delivery devices
include pressurized metered-dose inhalers, nebulizers, and valved holder chambers. They are
generally used as rescue therapy or permanent treatment for various respiratory disorders, such as
asthma, obstructive lung diseases, cystic fibrosis (CF), pulmonary arterial hypertension, and
infectious pulmonary. They are also utilized in treating non-respiratory conditions, including
diabetes, analgesia, thyroid disorders, and genetic diseases. They aid in lowering the dosage
requirements, minimizing systemic adverse effects, and improving the ability of patients to self-
administer medications. As a result, aerosol delivery devices find extensive applications in drug
delivery and treatment of various medical conditions.
Request for a PDF sample of this report: https://www.imarcgroup.com/aerosol-delivery-devices-
market/requestsample

4. Report Description
Report Description and Highlights
Global Aerosol Delivery Devices Market Trends:
The rising incidences of chronic respiratory diseases due to surging air pollution levels, allergens,
occupational risks, and unhealthy habits like smoking represent the primary factor driving the market
growth. Moreover, the sudden coronavirus disease (COVID-19) outbreak that causes acute respiratory
infections among patients is another major growth-inducing factor. In addition, there has been
widespread adoption of aerosol delivery devices in treating obstructive airway diseases at home and in
healthcare settings. Along with this, the expanding geriatric population that is more susceptible to
developing critical health conditions has augmented the product demand. Besides this, the increasing
preferences for personalized drug therapy coupled with the advent of novel macromolecular
medications have propelled market growth.
Furthermore, the leading manufacturers are introducing innovative product variants that assist in
treating chronic inflammation and infection in the lungs and improve airway clearance in patients with
CF. In line with this, the development of convenient, economical, and portable inhalation devices has
accelerated product adoption rates. Apart from this, the rising usage of e-commerce channels for
purchasing medical supplies and the availability of mini ultrasonic nebulizers and inhalers that have
automatic memory and are easy to use while traveling are providing a positive thrust to the market
growth.

5. Report Description
Report Description and Highlights
Looking forward, IMARC Group expects the market to reach US$ 63.3 Billion by 2028, exhibiting at a
CAGR of 5.4% during 2023-2028.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/aerosol-delivery-devices-market

6. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Product:
•Dry Powder Inhalers
• Single Dose Inhalers
• Multi Dose Inhalers
•Metered Dose Inhalers
• Conventional Pressurized Inhalers
• Soft Mist Inhalers
•Nebulizers
• Jet Nebulizers
• Ultrasonic Wave Nebulizers
• Vibrating Mesh Nebulizers
Breakup by Application:
•Asthma
•Chronic Obstructive Pulmonary Disease (COPD)
•Cystic Fibrosis

7. Report Description
Report Description and Highlights
•Non-Respiratory Diseases
• Diabetes
• Analgesia
• Parkinson’s Disease
Breakup by Distribution Channel:
•Retail Pharmacies
•Hospital Pharmacies
•Online Stores
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

8. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•3M Company
•Aerogen
•GlaxoSmithKline plc
•Johnson & Johnson
•Koninklijke Philips N.V
•Merck & Co. Inc
•Metall Zug AG
•Recipharm AB (publ)
•Teva Pharmaceutical Industries Ltd
•Vectura Group plc

9. Report Description
Key Questions Answered in the Report
1. What was the size of the global aerosol delivery devices market in 2022?
2. What is the expected growth rate of the global aerosol delivery devices market during 2023-
2028?
3. What are the key factors driving the global aerosol delivery devices market?
4. What has been the impact of COVID-19 on the global aerosol delivery devices market?
5. What is the breakup of the global aerosol delivery devices market based on the product?
6. What is the breakup of the global aerosol delivery devices market based on the distribution
channel?
7. What are the key regions in the global aerosol delivery devices market?
8. Who are the key players/companies in the global aerosol delivery devices market?

10. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Aerosol Delivery Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

11. Report Description Table of Contents
6 Market Breakup by Product
6.1 Dry Powder Inhalers
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Single Dose Inhalers
6.1.2.2 Multi Dose Inhalers
6.2 Metered Dose Inhalers
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Conventional Pressurized Inhalers
6.2.2.2 Soft Mist Inhalers
6.2.3 Market Forecast
6.3 Nebulizers
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Jet Nebulizers
6.3.2.2 Ultrasonic Wave Nebulizers
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/aerosol-delivery-devices-market/toc

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

14. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

15. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us